CanadaHuman ExperimentationVolunteersVaccines, AttenuatedHealthy VolunteersDouble-Blind MethodAdministration, OralCross-Over StudiesCholera VaccinesReference ValuesBacterial VaccinesAntibodies, BacterialAntibodies, ViralImmunoglobulin AArea Under CurveViral VaccinesInfluenza VaccinesFecesInfluenza A virusInjections, IntramuscularBiological AvailabilityVaccinationPolysaccharides, BacterialTime FactorsImmunoglobulin GAdministration, IntranasalHalf-LifeVaccines, SyntheticPlacebosInjections, IntravenousSingle-Blind MethodReproducibility of ResultsSalivaImmunization, SecondaryNasal MucosaOntarioDengue VirusHemagglutination Inhibition TestsDose-Response Relationship, DrugInfluenza, HumanNeuraminidaseMagnetic Resonance ImagingAntibody FormationAnalysis of VariancePilot ProjectsImmunoglobulin MRespirationNeutralization TestsBritish ColumbiaEnzyme-Linked Immunosorbent AssayDiarrheaAntibody SpecificityAlbertaQuebecAge FactorsBrainSensitivity and SpecificityAntigens, BacterialSex FactorsProspective StudiesManitobaHospital VolunteersTreatment OutcomeT-LymphocytesNova ScotiaNorthwest TerritoriesSaskatchewanNunavutYukon TerritoryNewfoundland and LabradorInuitsPrince Edward IslandArctic RegionsDrug InteractionsNew BrunswickQuestionnairesSingle-Payer SystemCase-Control StudiesIndians, North AmericanRisk FactorsGeeseNational Health ProgramsHeart RateInfusions, IntravenousGastric EmptyingPrevalenceMetabolic Clearance RateEmigration and ImmigrationDisease OutbreaksBlood PressureCross-Sectional StudiesChromatography, High Pressure LiquidIncidenceCohort StudiesBreath TestsPopulation SurveillanceAustraliaData CollectionAnti-Bacterial AgentsImage Processing, Computer-Assisted